Explore
Trendline
Novastra Therapeutics Appoints New CFO Amid Global Clinical Development Efforts
Novastra Therapeutics Appoints New CFO Amid Global Clinical Development Efforts
Read More
Trendline
Novastra Therapeutics Appoints New CFO to Propel Global Clinical Development
Novastra Therapeutics Appoints New CFO to Propel Global Clinical Development
Read More
Trendline
TRIANA Biomedicines Appoints Mohan Bala as COO, Expands Scientific Advisory Board
TRIANA Biomedicines Appoints Mohan Bala as COO, Expands Scientific Advisory Board
Read More
Trendline
Parabilis Medicines and Regeneron Pharmaceuticals Collaborate on Novel Therapeutics
Parabilis Medicines and Regeneron Pharmaceuticals Collaborate on Novel Therapeutics
Read More
Trendline
Palatin Technologies to List on Nasdaq, Enhancing Market Visibility
Palatin Technologies to List on Nasdaq, Enhancing Market Visibility
Read More
Trendline
Enveric Biosciences Reports First Quarter 2026 Financial Results and Advances Drug Development
Enveric Biosciences Reports First Quarter 2026 Financial Results and Advances Drug Development
Read More
Trendline
GenSight Biologics to Discuss Strategic Priorities at General Meeting
GenSight Biologics to Discuss Strategic Priorities at General Meeting
Read More
Trendline
Sensei Biotherapeutics Advances Cancer Treatment with PIKTOR Amid Financial Growth
Sensei Biotherapeutics Advances Cancer Treatment with PIKTOR Amid Financial Growth
Read More
Trendline
Sensei Biotherapeutics Advances Cancer Treatment Trials with PIKTOR, Reports Financial Growth
Sensei Biotherapeutics Advances Cancer Treatment Trials with PIKTOR, Reports Financial Growth
Read More
Trendline
Orca Bio Appoints Bijan Nejadnik, M.D., as Chief Medical Officer to Drive Clinical Strategy
Orca Bio Appoints Bijan Nejadnik, M.D., as Chief Medical Officer to Drive Clinical Strategy
Read More
Trendline
Aspera Biomedicines Launches ADAR1p150 Crystallization Experiment to ISS for Cancer Research
Aspera Biomedicines Launches ADAR1p150 Crystallization Experiment to ISS for Cancer Research
Read More
Trendline
Turn Therapeutics Appoints Former FDA Commissioner Dr. Stephen M. Hahn as Executive Clinical Lead
Turn Therapeutics Appoints Former FDA Commissioner Dr. Stephen M. Hahn as Executive Clinical Lead
Read More